cannabinoid and neurodegenerative / Junio 2016

Bibliografia de Junio 2016 del National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM) de EE.UU. publicada en el mundo acerca de enfermedades neuro-degenerativas y los cannabinoides

 

1: Manera C, Arena C, Chicca A. Synthetic cannabinoid receptor agonists and antagonists: implication in CNS disorders. Recent Pat CNS Drug Discov. 2016 May 19. [Epub ahead of print] PubMed PMID: 27193072.

2: López-Sendón Moreno JL, García Caldentey J, Trigo Cubillo P, Ruiz Romero C, García Ribas G, Alonso Arias MA, García de Yébenes MJ, Tolón RM, Galve-Roperh I, Sagredo O, Valdeolivas S, Resel E, Ortega-Gutierrez S, García-Bermejo ML, Fernández Ruiz J, Guzmán M, García de Yébenes Prous J. A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease. J Neurol. 2016 May 9. [Epub ahead of print] PubMed PMID: 27159993.


3: Stempel AV, Stumpf A, Zhang HY, Özdoğan T, Pannasch U, Theis AK, Otte DM, Wojtalla A, Rácz I, Ponomarenko A, Xi ZX, Zimmer A, Schmitz D. Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus. Neuron. 2016 May 18;90(4):795-809. doi: 10.1016/j.neuron.2016.03.034. Epub 2016 Apr 28. PubMed PMID: 27133464.

 

National Center for Biotechnology Information (NCBI)